Pre-and peristroke treatment with the adenosine kinase inhibitor, 5'-deoxyiodotubercidin, significantly reduces infarct volume after temporary occlusion of the middle cerebral artery in rats

Neuroscience Letters

Volumn 220, Issue 2, 1996, Pages 73-76

  Miller, Leonard P ^a   Jelovich, Laura A ^a   Yao, Liping ^a   Dare, Jay ^a   Ugarkar, Bhima ^a   Foster, Alan C ^a  

^a Gensia Inc   (United States)

Author keywords

Adenosine; Adenosine kinase; Adenosine kinase inhibitor; Adenosine regulating agent; Focal cerebral ischemia; Infarct volume; Middle cerebral artery occlusion

Indexed keywords

5' DEOXYIODOTUBERCIDIN; ADENOSINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; HISTOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOSINE KINASE; ANIMALS; CEREBRAL ARTERIES; CEREBRAL INFARCTION; CEREBROVASCULAR DISORDERS; CONSTRICTION, PATHOLOGIC; MALE; RATS; TUBERCIDIN;

EID: 0030582669     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(96)13234-1     Document Type: Article

References (20)

1. [1] Buchan, A.M., Do NMDA antagonists protect against cerebral ischemia: are clinical trials warranted?. Cerebrovasc. Brain Metab. Rev., 2 (1990) 1-26.
2. [2] Chen, H., Chopp, M. and Bodzin, G., Neutropenia reduces the volume of cerebral infarct after transient middle cerebral artery occlusion in the rat. Neurosci. Res. Commun., 11 (1992) 93-99.
3. [3] Chen, H., Chopp, M., Zhang, R.L., Bodzin, G., Chen, Q., Rusche, J.R. and Todd III, R.F., Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat. Ann. Neurol., 35 (1994) 447-452.
4. [4] Clark, W.M., Madden, K.P., Tothlein, R. and Zivin, J.A., Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecule, J. Neurosurg., 75 (1991) 623-627.
5. [5] Dietrich, W.D., Miller, L.P., Prado, R., Dewanjee, S., Alexis, N., Dewanjee, M.K. and Gruber, H., Acadesine reduces indium-labeled platelet deposition after photothrombosis of the common carotid artery in rats, Stroke, 26 (1995) 111-116.
6. [6] Fredholm, B.B., Purinoceptors in the nervous system, Pharmacol. Toxicol., 76 (1995) 228-239.
7. [7] Jiang, N., Moyle, M., Soule, H.R., Rote, W.E. and Chopp, M., Postischemic administration of the CD11b/CD18 antagonist neutrophil inhibitory factor (NIF) is neuroprotective after transient middle cerebral artery occlusion in rats, Stroke, 27 (1996) 188.
8. [8] Keil, G.J. and DeLander, G.E., Spinally-mediated antinociception is induced in mice by an adenosine kinase-, but not by an adenosine deaminase-, inhibitor, Life Sci., 51 (1992) 171-176.
9. [9] Koizumi, J., Yoshida, Y., Nakazawa, T. and Ooneda, G., Experimental studies of ischemic brain edema, 1: a new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area, Jpn. J. Stroke, 8 (1986) 1-8.
10. [10] Miller, L.P., Dixon, E., Hayes, R. and Foster, A.C. Acute treatment with an adenosine kinase inhibitor significantly reduces neurologic deficit in a rat model of traumatic brain injury, unpublished.
11. [11] Miller, L.P. and Hsu, C., Therapeutic potential for adenosine receptor activation in ischemic brain injury, J. Neurotrauma, 6 (1992) S563-S577.
12. [12] Miller, L.P, Chiang, P., Fujitake, J., Metzner, K. and Foster, A.C., Pretreatment with the adenosine regulating agent, GP668, significantly reduces brain infarct volume and neurologic deficits after temporary middle cerebral artery occlusion in rats, unpublished.
13. [13] Mullane, K., Bullough, D. and Shapiro, D., From academic vision to clinical reality: a case study of acadesine, Trends Cardiovasc. Med., 3 (1993) 227-234.
14. [14] Pak, M.A., Hass, H.L., Decking, U.K. and Schrader, J., Inhibition of adenosine kinase increases endogenous adenosine and depresses neuronal activity in hippocampal slices, Neuropharmacology, 33 (1994) 1049-1053.
15. [15] Phillis, J.W. and Smith-Barbour, M., The adenosine kinase inhibitor, 5 iodotubercidin, is not protective against cerebral ischemic injury in the gerbil, Life Sci., 53 (1993) 497-502.
16. [16] Pulsinelli, W.A., Jacewicz, J. and Buchan, A.M., Stroke and hypoxic ischemic disorders, In M.V. Johnston, R.L. MacDonald and A.B. Young (Eds.), Principles of Drug Therapy in Neurology, FA Davis. Philadelphia, 1992, pp. 118-160.
17. [17] Rudolphi, K.A., Schubert, P., Parkinson, F.E. and Fredholm, B.B., Adenosine and brain ischemia, Cerebrovasc. Brain Metab. Rev., 4 (1992) 346-369.
18. [18] Siesjo, B.K., Katsura, K., Pahlmark, K. and Smith, M.-L., The multiple causes of ischemic brain damage: a speculative synthesis. In J. Krieglstein and H. Berpichler Schwenk (Eds.), Pharmacology of Cerebral Ischemia, Wissenschaftliche Verlagsgesellchaft, Stuttgart, 1992, pp. 511-525.
19. [19] Zhang, G., Franklin, P.H. and Murray, T.F., Manipulation of endogenous adenosine in the rat prepiriform cortex modulates seizure susceptibility, J. Pharmacol. Exp. Ther., 264 (1993) 1415-1422.
20. [20] Zimring, S.T., Miller, L.P., Babb, M.J., Hill, G.M., DaRe, J., Ramirez-Weinhouse, M.M., Ugarkar, B.G., Gruber, H.E., Foster, A.C. and Wiesner, J.B., Adenosine kinase inhibitors exert anticonvulsant activity in rats and mice, Soc. Neurosci. Abstr. (1995) 366.